Membrane Filtration

Membrane Filtration is the compendial standard for quantifying the number of culturable microorganisms (bioburden) in a process stream. While it directly measures bioburden, its primary function in sterile manufacturing is to serve as a critical in-process control (IPC). The purpose of this IPC is to ensure the microbial load before the final sterilization step is low, thereby providing a high degree of assurance that the process will achieve the final quality attribute of Sterility.

• Legacy Technique: Direct Plating. For liquids with expected high counts, a small, fixed volume of the sample (e.g., 1 mL) is directly added to a petri dish with molten agar (pour plate) or spread onto the surface of solid agar (spread plate). This method is not suitable for large volumes or low-count samples typical in biologics manufacturing.
• Established Standard: Open Membrane Filtration. This is the current gold standard. Using a reusable filtration manifold (e.g., stainless steel), a sterile, disposable 0.45 µm membrane filter is placed, the sample is filtered, and the filter is aseptically transferred with forceps to a petri dish for incubation.
• Emerging Alternatives: Closed, Single-Use Systems. Systems like the MilliporeSigma Steritest™ or Milliflex® Oasis® use pre-sterilized, single-use filtration funnels and a peristaltic pump. This closed-system design minimizes the risk of environmental contamination during testing and improves reproducibility, making it the preferred modern approach.

The scientific principle of this method is size exclusion, followed by microbial cultivation. A membrane filter with a defined pore size (e.g., 0.45 µm) acts as a physical barrier, trapping microorganisms larger than its pores while allowing the liquid sample to pass through. The trapped, viable organisms are then provided with nutrient media and ideal growing conditions, allowing each individual cell to multiply into a macroscopically visible colony that can be counted.

• Output: A raw count of visible colonies on the membrane filter surface after incubation.
• Analysis: The raw count is converted into a final result based on the volume filtered (e.g., CFU/100 mL). This result is then compared against a pre-defined alert or action limit.
• Interpretation: A result exceeding the action limit indicates a potential loss of microbial control in the process. It triggers a formal investigation to identify the root cause, assess product impact, and implement corrective and preventive actions (CAPAs).

• High Sensitivity: Allows for the analysis of large sample volumes, enabling the detection of very low levels of contamination.
• Compendial Method: It is the globally compendial reference method (USP, EP, JP).
• Removes Inhibitors: The rinsing step can effectively remove antimicrobial properties of the drug product that might otherwise prevent microbial growth.

• Slow: The method is reliant on microbial growth, leading to a long time-to-result (typically 3-7 days). This delay means product is often moved forward at-risk before results are known.
• Detects Culturable Organisms Only: The method can only detect microorganisms that are capable of growing on the specific media and under the specific incubation conditions used (Viable But Not Culturable - VBNC - organisms are not detected).
• Requires Strict Aseptic Technique: The procedure involves multiple manual aseptic manipulations, creating a risk of accidental contamination from the analyst or the testing environment.

Validation follows the principles in USP <1227>. The most critical component is the Method Suitability Test (also known as Bacteriostasis and Fungistasis test).

• Purpose: To demonstrate that any residual antimicrobial properties of the product sample do not inhibit the growth of microorganisms on the filter after rinsing.
• Procedure: A small number (<100 CFU) of challenge microorganisms (e.g., Staphylococcus aureus, Bacillus subtilis, Candida albicans, Aspergillus brasiliensis) are inoculated. The recovery of these organisms from the product sample filter must be equivalent to their recovery from a control filter with no product.

• mAbs & Proteins: Standard for testing WFI, buffers, media, and in-process pools. The ability to rinse away preservative or high-concentration protein effects is critical.
• Cell & Gene Therapies: Essential for qualifying raw materials like media and buffers. Due to the nature of the final product, testing is focused on incoming materials and the manufacturing environment rather than the final cell product itself.